HCA Healthcare, Inc. $HCA Stock: Sumitomo Mitsui Trust Group Inc. Cuts Stake

Sumitomo Mitsui Trust Group Inc. lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 4.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 325,913 shares of the company’s stock after selling 14,683 shares during the period. Sumitomo Mitsui Trust Group Inc. owned 0.15% of HCA Healthcare worth $139,080,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the business. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of HCA Healthcare in the third quarter worth about $16,544,000. Vise Technologies Inc. increased its holdings in shares of HCA Healthcare by 17.5% during the 3rd quarter. Vise Technologies Inc. now owns 18,023 shares of the company’s stock valued at $7,691,000 after acquiring an additional 2,690 shares during the last quarter. Cidel Asset Management Inc. raised its stake in shares of HCA Healthcare by 5.6% in the 3rd quarter. Cidel Asset Management Inc. now owns 1,673 shares of the company’s stock valued at $714,000 after acquiring an additional 88 shares in the last quarter. Invera Wealth Advisors LLC raised its stake in shares of HCA Healthcare by 8.4% in the 3rd quarter. Invera Wealth Advisors LLC now owns 2,393 shares of the company’s stock valued at $1,021,000 after acquiring an additional 185 shares in the last quarter. Finally, MGO One Seven LLC lifted its holdings in HCA Healthcare by 34.8% in the 3rd quarter. MGO One Seven LLC now owns 1,575 shares of the company’s stock worth $672,000 after purchasing an additional 407 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Down 1.1%

Shares of NYSE:HCA opened at $467.89 on Tuesday. The company has a market cap of $101.30 billion, a price-to-earnings ratio of 15.50, a PEG ratio of 1.53 and a beta of 1.10. The business has a 50 day moving average price of $438.21 and a 200 day moving average price of $444.84. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, topping the consensus estimate of $6.65 by $0.57. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The company had revenue of $19.85 billion for the quarter, compared to the consensus estimate of $19.33 billion. During the same period in the previous year, the business posted $6.96 EPS. The company’s revenue for the quarter was up 3.6% on a year-over-year basis. Analysts anticipate that HCA Healthcare, Inc. will post 30.15 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, December 15th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s payout ratio is 10.34%.

HCA Healthcare News Roundup

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Wells Fargo raised its price target for HCA from $381 to $468 while maintaining an “equal weight” rating. The higher target reflects improved valuation support, although the rating signals limited expected upside at current levels. Wells Fargo HCA price-target update
• Positive Sentiment: HCA’s price target was also raised to $521 in a separate analyst update, while KeyCorp reportedly strengthened its earnings-per-share estimates. These revisions may support investor confidence in the company’s earnings outlook. HCA price target raised to $521 KeyCorp HCA EPS estimate update
• Neutral Sentiment: An HCA subsidiary is planning a senior-notes offering. The financing could provide capital for operations or investment, but it would also increase debt obligations; terms such as pricing and size will determine the ultimate impact. HCA subsidiary senior-notes offering HCA senior notes offering
• Neutral Sentiment: HCA released renderings for a planned $300 million hospital in Cape Coral, Florida, with tax support. The project points to long-term expansion but may require substantial capital before contributing meaningfully to earnings. HCA Cape Coral hospital project
• Negative Sentiment: A reported HCA data breach affected approximately 55,000 people, creating potential costs related to remediation, regulatory scrutiny and reputational damage. HCA data breach
• Negative Sentiment: Reports warn of payer pressure ahead of HCA’s 2027 outlook. Concerns over reimbursement rates and negotiations could weigh on margins and temper the benefit of stronger earnings estimates. HCA payer pressure outlook

Analysts Set New Price Targets

Several equities analysts have commented on the company. KeyCorp increased their price target on HCA Healthcare from $435.00 to $490.00 and gave the company an “overweight” rating in a report on Wednesday, October 28th. JPMorgan Chase & Co. reduced their price objective on shares of HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating for the company in a research note on Thursday, August 20th. Morgan Stanley decreased their price objective on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a report on Monday, July 27th. Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a research note on Friday, October 2nd. Finally, Royal Bank Of Canada lifted their target price on shares of HCA Healthcare from $496.00 to $521.00 and gave the stock an “outperform” rating in a report on Friday. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and an average target price of $479.48.

HCA Healthcare Company Profile

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.